Caribou Biosciences Holds Near $2 With June Cancer Drug Updates Ahead
Caribou Biosciences shares traded up Friday, sitting close to $2. Investors mostly shrugged off a slow news day, focusing instead on cancer-drug updates expected next month. The stock was at $2.01, about 1% higher than Thursday’s $1.99 close. It swung from $1.972 to $2.040. Market value stood near $198 million, according to Investing.com data.